Status:
COMPLETED
A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study assessed the efficacy and safety of Avastin in combination with docetaxel and cisplatin as first-line treatment of patients with metastatic or locally advanced non-small cell lung cancer. P...
Eligibility Criteria
Inclusion
- Adult patients, ≥ 18 years of age.
- Stage IIIb or IV non-small cell lung cancer.
- Chemotherapy-naive.
Exclusion
- Previous treatment for non-small cell lung cancer.
- Previous malignant tumor within last 5 years, except for basal cell skin cancer or preinvasive cervical cancer.
- Major surgical procedure, open biopsy, or significant traumatic injury within 28 days prior to start of study.
- Recent or current chronic treatment with aspirin (\> 325 mg/day).
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00661778
Start Date
July 1 2007
End Date
July 1 2011
Last Update
July 10 2014
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Palma de Mallorca, Balearic Islands, Spain, 07198
2
Cadiz, Cadiz, Spain, 11009
3
Castellon, Castellon, Spain, 12002
4
Donostia / San Sebastian, Guipuzcoa, Spain, 20080